HA-AMOT p130 Y287A Citations (1)
Originally described in: Angiomotin is a novel Hippo pathway component that inhibits YAP oncoprotein.Zhao B, Li L, Lu Q, Wang LH, Liu CY, Lei Q, Guan KL Genes Dev. 2011 Jan 1;25(1):51-63. PubMed Journal
Articles Citing HA-AMOT p130 Y287A
Articles |
---|
MAGI1 inhibits the AMOTL2/p38 stress pathway and prevents luminal breast tumorigenesis. Kantar D, Mur EB, Mancini M, Slaninova V, Salah YB, Costa L, Forest E, Lassus P, Geminard C, Boissiere-Michot F, Orsetti B, Theillet C, Colinge J, Benistant C, Maraver A, Heron-Milhavet L, Djiane A. Sci Rep. 2021 Mar 11;11(1):5752. doi: 10.1038/s41598-021-85056-1. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.